In 2018, FDA indicated Annovera from TherapeuticsMD to prevent pregnancy.
A drug-device combination, Annovera combines a ring-shaped vaginal delivery system with hormones. The manufacturer designed the device to remain in place for three weeks followed by removal for one week. The product is effective for up to one year (or 13 menstrual cycles).
The manufacturer describes it as the only “long-lasting, reversible contraception that is procedure-free.”
The product is the brainchild of the non-profit research organization Population Council.
Filed Under: Drug Delivery